jesse , If you are so gullible to believe the lost CF market is a positive- go stand in the corner with jad9blased.
You are correct ! The questions that stopped the clock ( kvnmbiowatchdog spam today a possible Nov decision is also blcht). The clock is stopped at 120 day because of CF questions- CF data was used to support the app. Insmed is considering pulling CF altogether to facilitate the filing. If that happens the clock MAY change. Until you get a clue and stop the blcht, you like the other clowns will be corrected. ))) Surfs up pal ! and remember to Have more fun !
since you got caught lying again biowatchkvncmcdd. . ARDM is a few years behind Insmed at this point and many have pointed that out. redvn2003 is a supporter of both co's. That was the point stupid! There is and will be competition. Witness the buffoonery last week with PAH ! Huge ! Insmed is doing fine but there are unknowns that real investors should be aware of, not blinded by clown posts of billions!
thats FALSE kvncmcdd(biowatchdog).You were caught lying before on this issue. The clock is stopped at day 120. The company said it hopes to answer all question by the end of the year .Best case is a few months after that.OT - who is making up all those IDs ? LOL ! Thanks to Cathy -
hi_lee_evolvd • Sep 16, 2015 5:12 PM
terny_insm • Sep 16, 2015 3:27 AM
4 dollar store returns to boot! you kids have a fun weekend? .. Sat morn I posted on the chart signal.. hmm deleted as well as my posts from last week...
superbullchtish kvncmcdd. American Bulls is an advertising site. LT investors are awaiting news. Actually the chart is a short term short. The uptrend for most of this year was broken in August. I sold taking my 159% money in the Bank. Have more fun.
kvnboheimian clown - No article . I understand TIP and Arikayce... you win todays foot in the mouth award
. My comments from years ago has nothing to do with antibiotic resistance.
Surfs up little boy
foot in the mouth as usual - what does my post about the short interest have to do with a Hedge fund?
I really should pick on jad9000 because she hasnt a clue, but she is SO MUCH Fun!
Last year I and others commented that perhaps the EMA will stall the app ( based on P2 data only) and wait for the FDA trial results ( the clock is now stopped at day 120 ) . The FDA saw something in the results that wasn't the slam dunk cure! clowns posted here. We all saw the negative "cures" but anyone here who has money in INSM and thinks Arikayce is a slam dunk (Blockbuster sales over a billion) in the FDA trial ( when most here had no idea of the mandated criteria) is foolish indeed. There is risk . I put it at 20% others 30%
Played here was my recent loss in XOMA , a drug with spectacular Phase2 results and 75% Institutions thinking like I did XOMA had a good shot - I understood the risk involved and this happens all the time in bio. With Arikayce I will be no where near INSM near decision time.
Success is NOT guaranteed- that you can take to the bank. YTD on the sidelines with 159% profits I love this stock!
The analysts must be crazy . The stock has simply churned since I got out ( say even ) but with no Money at risk with Insmed. Up 159% this year makes the wanna bees heads explode , $25 dollars and a 1.6 B valuations is still heady indeed. We now know that News ( as this is a news driven stock) will now not be received until an update of the clock restarting more than likely in the first quarter and a 270 clock
A catalyst? The market has helped make Insmed shares secure, but risk is possible. Next year is the trial ZZzzzzzzz
"Piper J $51 !-who would believe such a thing ?by terry_insm • Apr 25, 2014
Now that the clowns were corrected on the P3 refractory trial, they move to the failed drug Iplex! ,a sure sign of a poor Insmed investor ......I have made a lot of money Investing in Insmed in various positions over the years and I am a staunch supporter of Will Lewis Just because I am out or correct info doesn't mean I am "bashing " The Phase3 trial is for the most critical patients as an add on drug with the currently used common regimes. We shall see in a year and a half+ if the FDA will approve or expand the population " Insmed is all about NTM and the FDA trial that is enrolling. Iplex, as was mfg years ago is worthless
Grea bottom fishing setup SIGM + .67 x2k and out Lunch Money .
Have fun with the girls They love you ! YTD I am + 159%and out ,but watching.
Surfs up !
jad9000- I lived in San Francisco for 20yrs ! It's a Bay ! there is no surfing ......
FACT = arikayce is being trialed as an add on to commonly used regimes for refractory patients only
LOL ! Thanks to Cathy. Foot in the mouth clown - by jad9000 • Aug 15, 2015 9:40 AM "So, here we go with the refractory argument. The new bash is almost laughable."
What is laughable is jad9000 is a pumper with no medical or scientific background. Here on this investing bd jad9000 will now explain the SHORTS!! Have a fun day kids ! INSM is doing very well, but reality is for investors
Every couple of weeks kvncmcdd will plant a new bit of "DD" This is a rehash of old results presented by kvncmcdd as a wow!!! (also kvn=simabuzz=gt_pharma ...... Huge! Look day 84 !!., well we did look a year and a half ago and the results were very good (Arikayce failed the primary) so now investors will wait another year + for the FDA US results but kvncmdd may lead you to believe his DD will tell us more.
The Phase3 trial is for the most critical patients as an add on drug with the currently used common regimes. We shall see in a year and a half+ if the FDA will approve or expand the population.
Sorry I am not winkiewhenistudy, but I am amused. Who deleted my target price? Theres the market headfake, but traders are leaving anyway ( KBIO , yesterdays 5- 60 signal (2.70 ) + .90 and out.) Have fun on this board this weekend. SLO !
jad9000- I lived in San Francisco for 20yrs ! there is no surfing .........sorry just too funny.
jad9000 has a wonderful way of putting her foot in her mouth.....Raising cash in this market is a wise strategy near term.........A 620k sale is not a timed sale. . I am out INSM after taking YTD +159% profits.
jobs report was strong 5.1%
Yes Kvn, A cry . Insmed will not even be finished enrolling the Phase3 trial
I bet you look like the sad clown that cries .Watch your stock now kevie pivoting ..
Biotech watchers do not want anything like this near their drug applications.
After 90 days , the FDA would simply send the application back seeking " more information needed" as they do with many applications after a year. This bill is a disaster.... Politicizing the FDA has always proven to be a joke. ..I've had my fun and I see my target price was deleted ...Toooo bad!
Have more fun !
The jadkvn clowns are at it again. Do you believe the made up story about now We have MORE patients MORE money ,no doubt having more fun! ............Perhaps you fell for the stupid "Merck will mfg Iplex for us! , or many billions soon!....As soon as Will Lewis stated " "As we have said before, our historic interest in pursuing CF was not commercially driven." , as was explained the CF trial results were in the app to help NTM get a wider label. And so off to the Press went 2 clowns with absolutely no background to discuss the issue- it's Wikipedia! cut n paste!.
Informed Insmed investors know the NTM population is in question in both Europe and the US.
Will the EMA wait for Insmeds Phase3 results? limit the label on their own? or give a wide approval- no one knows as no one knows the results in the FDAs Phase3 trial. It's folly to fabricate revenues.
" Arikayce is being trialed as an adjunct therapy with patients that are refractory to treatment. " - this is 100% correct .Will responses to this be intelligent or more hysteria blcht or name calling ?.............. Watch
5,513,329 unexercised options !!! Talk about putting her foot in her mouth over and over
Hurry get that stupid post down! There are actually people here who know what that means!